论文部分内容阅读
目的探讨氨溴特罗口服液治疗支气管炎患儿的临床疗效以及对临床症状的改善作用。方法我院在2013年12月~2015年12月收治的支气管炎患儿中,选择具有可比性的110例作为研究对象,根据治疗方式的不同分为观察组与对照组,观察组患儿给予常规治疗后再给予氨溴特罗口服液治疗,对照组患儿给予常规治疗后再给予盐酸氨溴索糖浆治疗,分别对比两组患儿的临床疗效、各项呼吸道症状的缓解时间及各项呼吸道症状的评分。结果两组患儿的临床疗效存在显著差异,观察组患儿的临床疗效明显高于对照组患儿的临床疗效;两组患儿的各项呼吸道症状缓解时间存在显著差异,观察组患儿的各项呼吸道症状缓解时间明显短于对照组患儿的各项呼吸道症状缓解时间;两组患儿的各项呼吸道症状评分存在显著差异,观察组患儿的各项呼吸道症状评分明显低于对照组患儿的各项呼吸道症状评分;P<0.05为差异具有统计学意义。结论氨溴特罗口服液治疗支气管炎效果显著,改善呼吸道临床症状明显,值得临床的推广及应用。
Objective To investigate the clinical efficacy of ambroxol oral liquid in the treatment of children with bronchitis and to improve the clinical symptoms. Methods A total of 110 patients with bronchitis admitted to our hospital from December 2013 to December 2015 were selected as the research object and divided into observation group and control group according to different treatment methods. After treatment, ambroxol oral solution was given to the patients in the control group, and ambroxol hydrochloride syrup was given to the children in the control group after routine treatment. The clinical efficacy, respiratory relief time, Respiratory symptoms score. Results There was a significant difference in the clinical efficacy between the two groups. The clinical efficacy of the observation group was significantly higher than that of the control group. There was significant difference in the relief time of various respiratory symptoms between the two groups. In the observation group, Respiratory symptoms were significantly shorter than those in the control group. The scores of respiratory symptoms in both groups were significantly different. The scores of respiratory symptoms in the observation group were significantly lower than those in the control group Respiratory symptoms in children score; P <0.05 for the difference was statistically significant. Conclusion Ambroxol oral solution for the treatment of bronchitis significant effect of improving the clinical symptoms of the respiratory tract obvious, worthy of clinical promotion and application.